GenScript Biotech Corporation will hold a board meeting on Sunday, 15 March 2026 to consider and approve the group’s annual results for the year ended 31 December 2025, the publication of those results, and the payment of an annual dividend, if any.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260304-12039704), on March 04, 2026, and is solely responsible for the information contained therein.
Comments